Incidence and expression of circulating cell free p53-related genes in acute myocardial infarction patients

Journal of Atherosclerosis and Thrombosis

Volumn 22, Issue 9, 2015, Pages 981-998

  Pereg, David ^a,b   Cohen, Keren ^a,b,c   Mosseri, Morris ^a,b   Berlin, Tatiana ^a,b   Steinberg, David M ^b   Ellis, Martin ^a,b   Ashur Fabian, Osnat ^a,b,c  

^a MEIR MEDICAL CENTER   (Israel)

^b TEL AVIV UNIVERSITY   (Israel)

^c Department of Human Molecular Genetics and Biochemistry ^*  (Israel)

Author keywords

Acute MI; Biomarker; P53; Plasma; RNA

Indexed keywords

HYPOXIA INDUCIBLE FACTOR 1ALPHA; NOTCH1 RECEPTOR; P21 ACTIVATED KINASE; PROTEIN; PROTEIN BNIP3; PROTEIN BTG2; PROTEIN ERCC5; PROTEIN MDM2; PROTEIN P53; TRANSFORMING GROWTH FACTOR BETA3; UNCLASSIFIED DRUG; VASCULOTROPIN A; BNIP3L PROTEIN, HUMAN; BTG2 PROTEIN, HUMAN; CDKN1A PROTEIN, HUMAN; CYCLIN DEPENDENT KINASE INHIBITOR 1A; IMMEDIATE EARLY PROTEIN; MEMBRANE PROTEIN; NOTCH1 PROTEIN, HUMAN; ONCOPROTEIN; OXYGEN; RNA; TP53 PROTEIN, HUMAN; TUMOR SUPPRESSOR PROTEIN;

ACUTE HEART INFARCTION; ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL ASSESSMENT; CONTROLLED STUDY; ECHOCARDIOGRAPHY; HUMAN; MALE; MICROARRAY ANALYSIS; MYOCARDIAL PERFUSION IMAGING; PERCUTANEOUS CORONARY INTERVENTION; PREVALENCE; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; ACUTE DISEASE; AGED; AREA UNDER THE CURVE; BLOOD; CHEMISTRY; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENETICS; INCIDENCE; MIDDLE AGED; MYOCARDIAL INFARCTION; PERFUSION; PROGNOSIS; TUMOR SUPPRESSOR GENE; VERY ELDERLY;

ACUTE DISEASE; ADULT; AGED; AGED, 80 AND OVER; AREA UNDER CURVE; CYCLIN-DEPENDENT KINASE INHIBITOR P21; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENES, P53; HUMANS; IMMEDIATE-EARLY PROTEINS; INCIDENCE; MALE; MEMBRANE PROTEINS; MIDDLE AGED; MYOCARDIAL INFARCTION; OXYGEN; PERCUTANEOUS CORONARY INTERVENTION; PERFUSION; PROGNOSIS; PROTO-ONCOGENE PROTEINS; RECEPTOR, NOTCH1; RNA; TUMOR SUPPRESSOR PROTEIN P53; TUMOR SUPPRESSOR PROTEINS;

EID: 84941649449     PISSN: 13403478     EISSN: 18803873     Source Type: Journal    
DOI: 10.5551/jat.29223     Document Type: Article

References (50)

1. Thygesen K, Alpert JS, Jaffe AS, Simoons ML, Chaitman BR, White HD, Thygesen K, Alpert JS, White HD, Jaffe AS, Katus HA, Apple FS, Lindahl B, Morrow DA, Chaitman BR, Clemmensen PM, Johanson P, Hod H, Underwood R, Bax JJ, Bonow JJ, Pinto F, Gibbons RJ, Fox KA, Atar D, Newby LK, Galvani M, Hamm CW, Uretsky BF, Steg PG, Wijns W, Bassand JP, Menasche P, Ravkilde J, Ohman EM, Antman EM, Wallentin LC, Armstrong PW, Simoons ML, Januzzi JL, Nieminen MS, Gheorghiade M, Filippatos G, Luepker RV, Fortmann SP, Rosamond WD, Levy D, Wood D, Smith SC, Hu D, Lopez-Sendon JL, Robertson RM, Weaver D, Tendera M, Bove AA, Parkhomenko AN, Vasilieva EJ, Mendis S, Bax JJ, Baumgartner H, Ceconi C, Dean V, Deaton C, Fagard R, Funck-Bren tano C, Hasdai D, Hoes A, Kirchhof P, Knuuti J, Kolh P, McDonagh T, Moulin C, Popescu BA, Reiner Z, Sechtem U, Sirnes PA, Tendera M, Torbicki A, Vahanian A, Windecker S, Morais J, Aguiar C, Almahmeed W, Arnar DO, Barili F, Bloch KD, Bolger AF, Botker HE, Bozkurt B, Bugiardini R, Cannon C, de Lemos J, Eberli FR, Escobar E, Hlatky M, James S, Kern KB, Moliterno DJ, Mueller C, Neskovic AN, Pieske BM, Schulman SP, Storey RF, Taubert KA, Vranckx P, Wagner DR: Third universal definition of myocardial infarction. J Am Coll Cardiol, 2012; 60: 1581-1598
2. Mueller M, Vafaie M, Biener M, Giannitsis E, Katus HA: Cardiac troponin T: from diagnosis of myocardial infarction to cardiovascular risk prediction. Circ J, 2013; 77: 1653-1661
3. Raskovalova T, Twerenbold R, Collinson PO, Keller T, Bouvaist H, Folli C, Giavarina D, Lotze U, Eggers KM, Dupuy AM, Chenevier-Gobeaux C, Meune C, Maisel A, Mueller C, Labarere J: Diagnostic accuracy of combined cardiac troponin and copeptin assessment for early ruleout of myocardial infarction: a systematic review and meta-analysis. Eur Heart J Acute Cardiovasc Care, 2014; 3: 18-27
4. Mahajan VS, Jarolim P: How to interpret elevated cardiac troponin levels. Circulation, 2011; 124: 2350-2354
5. Kruse JP, Gu W: Modes of p53 regulation. Cell, 2009; 137: 609-622
6. Brady CA, Attardi LD: p53 at a glance. J Cell Sci, 2010; 123: 2527-2532
7. Riley T, Sontag E, Chen P, Levine A: Transcriptional control of human p53-regulated genes. Nat Rev Mol Cell Biol, 2008; 9: 402-412
8. Hoshino A, Matoba S, Iwai-Kanai E, Nakamura H, Kimata M, Nakaoka M, Katamura M, Okawa Y, Ariyoshi M, Mita Y, Ikeda K, Ueyama T, Okigaki M, Matsubara H: p53-TIGAR axis attenuates mitophagy to exacerbate cardiac damage after ischemia. J Mol Cell Cardiol, 2012; 52: 175-184
9. Naito AT, Okada S, Minamino T, Iwanaga K, Liu ML, Sumida T, Nomura S, Sahara N, Mizoroki T, Takashima A, Akazawa H, Nagai T, Shiojima I, Komuro I: Promotion of CHIP-mediated p53 degradation protects the heart from ischemic injury. Circ Res, 2010; 106: 1692-1702
10. Tsui NB, Ng EK, Lo YM: Molecular analysis of circulating RNA in plasma. Methods Mol Biol, 2006; 336: 123-134
11. Tsui NB, Lo YM: Placental RNA in maternal plasma: toward noninvasive fetal gene expression profiling. Ann N Y Acad Sci, 2006; 1075: 96-102
12. Butt AN, Swaminathan R: Overview of circulating nucleic acids in plasma/serum. Ann N Y Acad Sci, 2008; 1137: 236-242
13. Kumarswamy R, Thum T: Non-coding RNAs in cardiac remodeling and heart failure. Circ Res, 2013; 113: 676-689
14. Ashur-Fabian O, Yerushalmi GM, Mazaki-Tovi S, Steinberg DM, Goldshtein I, Yackobovitch-Gavan M, Schiff E, Amariglio N, Rechavi G: Cell free expression of hif1alpha and p21 in maternal peripheral blood as a marker for preonly eclampsia and fetal growth restriction. PLoS One, 2012; 7: e37273
15. Anker P, Stroun M: Progress in the knowledge of circulating nucleic acids: plasma RNA is particle-associated. Can it become a general detection marker for a cancer blood test ? Clin Chem, 2002; 48: 1210-1211
16. Hasselmann DO, Rappl G, Tilgen W, Reinhold U: Extracellular tyrosinase mRNA within apoptotic bodies is protected from degradation in human serum. Clin Chem, 2001; 47: 1488-1489
17. Tsui NB, Ng EK, Lo YM: Stability of endogenous and added RNA in blood specimens, serum, and plasma. Clin Chem, 2002; 48: 1647-1653
18. Ng EK, Tsui NB, Lau TK, Leung TN, Chiu RW, Panesar NS, Lit LC, Chan KW, Lo YM: mRNA of placental origin is readily detectable in maternal plasma. Proc Natl Acad Sci U S A, 2003; 100: 4748-4753
19. Rykova EY, Wunsche W, Brizgunova OE, Skvortsova TE, Tamkovich SN, Senin IS, Laktionov PP, Sczakiel G, Vlassov VV: Concentrations of circulating RNA from healthy donors and cancer patients estimated by different methods. Ann N Y Acad Sci, 2006; 1075: 328-333
20. Tani N, Ichikawa D, Ikoma D, Tomita H, Sai S, Ikoma H, Okamoto K, Ochiai T, Ueda Y, Otsuji E, Yamagishi H, Miura N, Shiota G: Circulating cell-free mRNA in plasma as a tumor marker for patients with primary and recurrent gastric cancer. Anticancer Res, 2007; 27: 1207-1212
21. Robin X, Turck N, Hainard A, Tiberti N, Lisacek F, Sanchez JC, Muller M: pROC: an open-source package for R and S＋ to analyze and compare ROC curves. BMC Bioinformatics, 2011; 12: 77
22. Poon LL, Leung TN, Lau TK, Lo YM: Presence of fetal RNA in maternal plasma. Clin Chem, 2000; 46: 1832-1834
23. Tijsen AJ, Pinto YM, Creemers EE: Circulating microRNAs as diagnostic biomarkers for cardiovascular diseases. Am J Physiol Heart Circ Physiol, 2012; 303: H1085-1095
24. Matsumoto S, Sakata Y, Nakatani D, Suna S, Mizuno H, Shimizu M, Usami M, Sasaki T, Sato H, Kawahara Y, Hamasaki T, Nanto S, Hori M, Komuro I: A subset of circulating microRNAs are predictive for cardiac death after discharge for acute myocardial infarction. Biochem Biophys Res Commun, 2012; 427: 280-284
25. Omran A, Elimam D, He F, Peng J, Yin F: Potential role of blood microRNAs as non-invasive biomarkers for early detection of asymptomatic coronary atherosclerosis in obese children with metabolic syndrome. Med Hypotheses, 2012; 79: 889-893
26. Matsumoto S, Sakata Y, Suna S, Nakatani D, Usami M, Hara M, Kitamura T, Hamasaki T, Nanto S, Kawahara Y, Komuro I: Circulating p53-responsive microRNAs are predictive indicators of heart failure after acute myocardial infarction. Circ Res, 2013; 113: 322-326
27. Akat KM, Moore-McGriff D, Morozov P, Brown M, Gogakos T, Correa Da Rosa J, Mihailovic A, Sauer M, Ji R, Ramarathnam A, Totary-Jain H, Williams Z, Tuschl T, Schulze PC: Comparative RNA-sequencing analysis of myocardial and circulating small RNAs in human heart failure and their utility as biomarkers. Proc Natl Acad Sci U S A, 2014;
28. Jung YS, Qian Y, Chen X: Examination of the expanding pathways for the regulation of p21 expression and activity. Cell Signal, 2010; 22: 1003-1012
29. Ahuja P, Sdek P, MacLellan WR: Cardiac myocyte cell cycle control in development, disease, and regeneration. Physiol Rev, 2007; 87: 521-544
30. Wang D, Zhang YZ, Yang B, Zhang FX, Cao MY, Wang C, Chen ML: p21 WAF1 and hypoxia/reoxygenationinduced premature senescence of H9c2 cardiomyocytes. Folia Histochem Cytobiol, 2011; 49: 445-451
31. Corroyer S, Maitre B, Cazals V, Clement A: Altered regulation of G1 cyclins in oxidant-induced growth arrest of lung alveolar epithelial cells. Accumulation of inactive cyclin E-DCK2 complexes. J Biol Chem, 1996; 271: 25117-25125
32. Sen CK, Khanna S, Roy S: Perceived hyperoxia: oxygeninduced remodeling of the reoxygenated heart. Cardiovasc Res, 2006; 71: 280-288
33. Roy S, Khanna S, Bickerstaff AA, Subramanian SV, Atalay M, Bierl M, Pendyala S, Levy D, Sharma N, Venojarvi M, Strauch A, Orosz CG, Sen CK: Oxygen sensing by primary cardiac fibroblasts: a key role of p21 (Waf1/Cip1/ Sdi 1). Circ Res, 2003; 92: 264-271
34. Roy S, Khanna S, Rink T, Radtke J, Williams WT, Biswas S, Schnitt R, Strauch AR, Sen CK: P21waf1/cip1/sdi1 as a central regulator of inducible smooth muscle actin expression and differentiation of cardiac fibroblasts to myofibroblasts. Mol Biol Cell, 2007; 18: 4837-4846
35. Kuhn DE, Roy S, Radtke J, Khanna S, Sen CK: Laser microdissection and capture of pure cardiomyocytes and fibroblasts from infarcted heart regions: perceived hyperoxia induces p21 in peri-infarct myocytes. Am J Physiol Heart Circ Physiol, 2007; 292: H1245-1253
36. Yang ZY, Simari RD, Perkins ND, San H, Gordon D, Nabel GJ, Nabel EG: Role of the p21 cyclin-dependent kinase inhibitor in limiting intimal cell proliferation in response to arterial injury. Proc Natl Acad Sci U S A, 1996; 93: 7905-7910
37. Li Y, Cai M, Sun Q, Liu Z, Cardounel AJ, Swartz HM, He G: Hyperoxia and transforming growth factor beta1 signaling in the post-ischemic mouse heart. Life Sci, 2013; 92: 547-554
38. Hauck L, Hansmann G, Dietz R, von Harsdorf R: Inhibition of hypoxia-induced apoptosis by modulation of retinoblastoma protein-dependent signaling in cardiomyocytes. Circ Res, 2002; 91: 782-789
39. Adachi S, Ito H, Tamamori-Adachi M, Ono Y, Nozato T, Abe S, Ikeda M, Marumo F, Hiroe M: Cyclin A/cdk2 activation is involved in hypoxia-induced apoptosis in cardiomyocytes. Circ Res, 2001; 88: 408-414
40. Liu Z, Yang D, Xie P, Ren G, Sun G, Zeng X, Sun X: MiR-106b and MiR-15b modulate apoptosis and angiogenesis in myocardial infarction. Cell Physiol Biochem, 2012; 29: 851-862
41. Galvez AS, Brunskill EW, Marreez Y, Benner BJ, Regula KM, Kirschenbaum LA, Dorn GW, II: Distinct pathways regulate proapoptotic Nix and BNip3 in cardiac stress. J Biol Chem, 2006; 281: 1442-1448
42. Dorn GW, II: Nix Nought Nothing: fairy tale or real deal. J Mol Cell Cardiol, 2011; 51: 497-500
43. Yussman MG, Toyokawa T, Odley A, Lynch RA, Wu G, Colbert MC, Aronow BJ, Lorenz JN, Dorn GW, II: Mitochondrial death protein Nix is induced in cardiac hypertrophy and triggers apoptotic cardiomyopathy. Nat Med, 2002; 8: 725-730
44. Wu AH, Christenson RH: Analytical and assay issues for use of cardiac troponin testing for risk stratification in primary care. Clin Biochem, 2013;
45. Lim IK: TIS21 (/BTG2/PC 3) as a link between ageing and cancer: cell cycle regulator and endogenous cell death molecule. J Cancer Res Clin Oncol, 2006; 132: 417-426
46. Simkhovich BZ, Marjoram P, Poizat C, Kedes L, Kloner RA: Age-related changes of cardiac gene expression following myocardial ischemia/reperfusion. Arch Biochem Biophys, 2003; 420: 268-278
47. Carmel JB, Kakinohana O, Mestril R, Young W, Marsala M, Hart RP: Mediators of ischemic preconditioning identified by microarray analysis of rat spinal cord. Exp Neurol, 2004; 185: 81-96
48. Fiedler F, Mallo GV, Bodeker H, Keim V, Dagorn JC, Iovanna JL: Overexpression of the PC3/TIS21/BTG2 mRNA is part of the stress response induced by acute pancreatitis in rats. Biochem Biophys Res Commun, 1998; 249: 562-565
49. Gogna R, Madan E, Khan M, Pati U, Kuppusamy P: p53’s choice of myocardial death or survival: Oxygen protects infarct myocardium by recruiting p53 on NOS3 promoter through regulation of p53-Lys (118) acetylation. EMBO Mol Med, 2013; 5: 1662-1683
50. Janicke RU, Sohn D, Schulze-Osthoff K: The dark side of a tumor suppressor: anti-apoptotic p53. Cell Death Differ, 2008; 15: 959-976